Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus Inc (NQ: SLP )

39.99 +1.57 (+4.10%)
Streaming Delayed Price Updated: 12:52 PM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Simulations Plus Inc

< Previous 1 2 3 4 Next >
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Names Sharlene Evans to Board of Directors
From Simulations Plus, Inc.
Via Business Wire
Axie Infinity Crypto Yield Games
We Pay - You Play - You Earn 
Via IssueWire
Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases GastroPlus® Version 9.8.2
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Announces the University+ Program
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Announces Cash Dividend
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases ADMET Predictor® (X.3)
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Receives New Grant Award From the FDA
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
From Simulations Plus, Inc.
Via Business Wire
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25 Years in Business
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Uplisted to The Nasdaq Global Select Market®
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases ADMET Predictor® (X.2)
From Simulations Plus, Inc.
Via Business Wire
U.S. FDA Renews Licenses of DILIsym Software
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.